Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanofi (GB:0A2V)
LSE:0A2V
Holding GB:0A2V?
Track your performance easily
See the Price Targets and Ratings of:
0A2V Analyst Ratings
Moderate Buy
2 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0A2V Stock 12 Month Forecast
Average Price Target
$63.67
▲(11.27% Upside)
| Highest Price Target$67.00 | Average Price Target$63.67 | Lowest Price Target$60.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
Reiterated
09/11/24
Berenberg Bank
Reiterated
09/10/24
Argus Research
Reiterated
07/26/24
Citi
―
Buy
―
Reiterated
02/01/24
Sanofi (SNY) shares slide following Q4 revenue missReacting to the report, Citi analyst Peter Verdult said the underlying story is unchanged for the company.
Morgan Stanley
―
Hold
―
Reiterated
02/01/24
Sanofi (SNY) shares slide following Q4 revenue missMorgan Stanleys Mark Purcell kept an Equal-Weight rating on SNY, saying they expect Sanofi shares to be broadly flat to slightly down, "with a small miss on 4Q23 Q23 expectations and FY24 guidance implying a small FX-based cut to consensus.
Jefferies
$64→$63
Buy
10.10%
Upside
Reiterated
01/16/24
Sanofi price target lowered to $63 from $64 at JefferiesSanofi price target lowered to $63 from $64 at Jefferies
Unknown Analyst
Not Ranked
DBS
$67
Buy
17.09%
Upside
Reiterated
05/27/24
We have a BUY rating on Sanofi, with TP of USD67.0. We have a BUY rating on Sanofi, with TP of USD67.0. Our TP is based on 14x 25F PE, which is on par with its ten-year average. Our BUY rating is premised on: 1) The company being a global leader in the generic drugs industry, thanks to its strong capability in API production; 2) it having a rich pipeline of drugs under different stages of clinical trial, which can fuel future growth; and 3) the post-COVID resumption of activities in hospitals globally, which will drive the demand for drugs.
Best Analysts Covering Sanofi
Which Analyst Should I Follow If I Want to Buy GB:0A2V and Sell After:
1 Month
xxx
Success Rate
4/6 ratings generated profit
Average Return
+0.33%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +0.33% per trade.
3 Months
xxx
Success Rate
4/6 ratings generated profit
Average Return
+1.58%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +1.58% per trade.
1 Year
Success Rate
5/6 ratings generated profit
Average Return
+5.30%
reiterated a buy rating 17 days ago
Copying Luisa Hector's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +5.30% per trade.
2 Years
xxx
Success Rate
5/6 ratings generated profit
Average Return
+5.30%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +5.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0A2V Analyst Recommendation Trends
Rating
Feb 24
May 24
Jun 24
Jul 24
Sep 24
Strong Buy
0
0
0
0
0
Buy
2
4
4
6
6
Hold
3
3
2
1
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
7
6
7
8
Each month's total comprises the sum of three months' worth of ratings.
0A2V Financial Forecast
0A2V Stock Forecast FAQ
What is GB:0A2V’s average 12-month price target, according to analysts?
Based on analyst ratings, Sanofi’s 12-month average price target is $63.67.
What is GB:0A2V’s upside potential, based on the analysts’ average price target?
Sanofi has 11.27% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sanofi a Buy, Sell or Hold?
Sanofi has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
What is Sanofi’s share price target?
The average share price target for Sanofi is $63.67. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $67.00 ,and the lowest forecast is $60.00. The average share price target represents 11.27% Increase from the current price of $57.223.
The highest analyst share price target is $67.00 ,and the lowest forecast is $60.00. The average share price target represents 11.27% Increase from the current price of $57.223.
What do analysts say about Sanofi?
Sanofi’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of Sanofi?
To buy shares of GB:0A2V, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.